PROP

0.28817.06%
LJ

Louis J. Basenese

Independent Director

Mr. Louis J. Basenese, also known as Lou, is Independent Director of ClearSign Technologies Corporation from May 22, 2025. He serves as Executive Vice President at Prairie Operating Co., LLC since 2026 and was its Executive Vice President of Market Strategy since January 2025 until 2026. He also served as President & Chief Market Strategist at Public Ventures, LLC since October 2022 until January 2025. Mr. Basenese has been an Independent Director at ENDRA Life Sciences Inc. since April 9, 2020. He was previously the Investment Director at Wall Street Daily, LLC, where he also served as Chief Investment Strategist and Chief Technology Analyst, co-founding the firm. With experience in equity research and analysis, investment banking, strategic planning and communications, Mr. Basenese has a strong background in identifying promising technology trends and public companies. He was the Founder and Chief Analyst at Disruptive Tech Research LLC from June 2014 through September 2022. Prior to this, he worked as an Investment Consultant at Morgan Stanley and held various roles as a Wall Street Consultant and Analyst. Mr. Basenese's investment approach combines behavioral finance, particularly hype cycles of technology adoption, with a top-down analysis of patent filing activity to identify technology trends. He employs traditional, bottom-up fundamental analysis to uncover under-followed, under-appreciated and undervalued micro- and small-cap ideas. He appears regularly on CNBC's Closing Bell and has had his analysis featured in various media outlets, including The Wall Street Journal, The New York Times, Morningstar, Business Insider, Forbes and MarketWatch. Since 2005, Mr. Basenese has managed The Basenese Group, LLC, a consulting business focused on communications and business development for private and public small and microcap businesses. He is a former Series 7 and Series 66 license holder and co-founded one of the web's larger financial publishers, which has a daily circulation of more than 700,000 investors. Mr. Basenese serves on the board of directors of ENDRA Life Sciences Inc. and The Roberto Clemente Health Clinic, a U.S.-based non-profit that provides affordable access to high-quality health care and wellness programs in the Tola coastal communities of Nicaragua. He previously served as President and Chief Market Strategist of MDB Capital Holdings, LLC and has held various analyst, strategist and account executive roles in the financial services and research industries. Mr. Basenese earned his MBA degree with a focus in Finance from the Crummer Graduate School of Business at Rollins College and holds a Bachelor of Arts from the University of Florida.

Positions